Visceral adiposity cut-off points to indicate risk factor to develop the nonalcoholic fatty liver disease in Brazilian and Italian obese adolescents

e-SPEN

Volumn 5, Issue 5, 2010, Pages

  Caranti, Danielle Arisa ^a   Sartorio, Alessandro ^b   de Piano, Aline ^a   Tock, Lian ^a   Lederman, Henrique ^a   Minocci, Alessandro ^b   Agosti, Fiorenza ^b   Patrizi, Alessandra ^b   Túlio de Mello, Marco ^a   Tufik, Sérgio ^a   Lafortuna, Claudio ^c   Dâmaso, Ana R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

Liver disease; Obesity; Visceral adipose tissue; Youth

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BODY FAT DISTRIBUTION; BRAZIL; FEMALE; HUMAN; INSULIN RESISTANCE; ITALY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; OBESITY; RISK FACTOR;

EID: 78049231460     PISSN: 17514991     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2010.06.001     Document Type: Article

References (27)

1. Shaibi G.Q., Cruz M.L., Ball G.D.C., Weigensberg M.J., Kobaissi H.A., Salem G.J., et al. Cardiovascular fitness and metabolic syndrome in overweight Latino youths. Med Sci Sports Exerc 2005, 37(6):922-928.
2. Caranti D.A., Mello M.T., Prado W.L., Tock L., Siqueira K., de Piano A., et al. Short and long term beneficial effects. Metabolism 2007, 56(9):1293-1300.
3. Lobstein T., Frelut M.L. Prevalence of overweight among children in Europe. Obes Rev 2003, 4:195-200.
4. Hamaguchi Kojima T., Takeda N., Nakagawa T., Taniguchi H., Fujii K., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005 Nov 15, 143(10):722-728.
5. Abdelmalek M.F., Sanderson S.O., Angulo P., Soldevilla-Pico C., Liu C., Peter J., et al. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology 2009, 50(6):1818-1826.
6. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and metabolic syndrome. Hepatology 2003, 37:917-923.
7. Bugianesi E., Gastaldelli A., Vanni E., Gambino R., Cassader M., Baldi S., et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005, 48(4):634-642.
8. Ong J.P., Younossi Z.M. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Clin Liver Dis 2005, 9(4):617-634.
9. Caranti D.A., Lazzer S., Dâmaso A.R., Agosti F., Zenaro R., de Mello M.T., et al. Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents: a comparison study. Int J Clin Pract 2008, 62(10):1526-1532.
10. Fishbein M.H., Mogren C., Gleason T., Stevens W.R. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2006, 42(1):83-88.
11. Willner I.R., Waters B., Patil S.R., Reuben A., Morelli J., Riely D.A., et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001, 96:2957-2961.
12. Horie L.M., Barbosa-Silva M.C., Torrinhas R.S., de Mello M.T., Cecconello I., Waitzberg D.L. New body fat prediction equations for severely obese patients. Clin Nutr 2008, 27(3):350-356.
13. Dâmaso A.R., Prado W.L., de Piano A., Tock L., Caranti D.A., Lofrano M., et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis 2008, 40:132-139.
14. Center for disease control and prevention Prevalence of overweight among children and adolescents: United States [accessed October 2009]. http://www.cdc.gov/growthcharts/htm.
15. Tanner J.M. Growth at adolescence 1961, United Kingdom, Oxford. 2nd ed.
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
17. Dâmaso A.R., Tock L., Tufik S., do Prado W.L., Stella S., Fisberg M., et al. Tratamento Multidisciplinar reduz o tecido adiposo visceral, leptina, grelina e a prevalência de esteatose hepática não alcoólica (NAFLD) em adolescentes obesos. Rev Bras de Medicina do Esporte 2006, 12(5):263-267.
18. Ribeiro-Filho F.F., Faria N.A., Ajzen S., Zanella M.T., Ferreira S.R. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res 2003, 11:1488-1494.
19. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
20. Esteghamati A., Ashraf H., Khalilzadeh O., Zandieh A., Nakhjavani M., Rashidi A., et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable disease in Iran. Nutr Metab 2010, 7:26.
21. Manco M., Marcellini M., Gremana G., Nobili V. Correlation of serum TNF-α levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol 2007, 127:954-960.
22. de Piano, Tock L., Carnier J., Foschini D., Sanches P.L., Correa F.A., et al. The role of nutritional profile in the orexigenic neuropeptides secretion in NAFLD. Eur J Gastroenterol Hepatol 2010, 22(5):557-563.
23. van der Poorten D., Milner K.L., Hui J., Hodge A., Trenell Ml, Kench J.G., et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008, 48:449-457.
24. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
25. de Piano, Prado W.L., Caranti D.A., Siqueira K., Stella S.G., Lofrano M., et al. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2007, 44(4):446-452.
26. Dâmaso A.R., de Piano A., Tock L., Srirajaskanthan R. Nutritional and clinical strategies on the prevention and treatment of NAFLD and metabolic syndrome. Nutrition, diet therapy and the liver 2009, 113-130. (Org.), Taylor & Francis Group, Boca Raton - Florida; London. 1st ed. V.R. Preedy, R. Srirajaskanthan, R. Lakshman, R.R. Watson (Eds.).
27. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., Lavine J.E. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003, 143(4):500-505.